Evidence map›Paper›PMID 37732479›Full record

ReviewHypertension (Dallas, Tex. : 1979)2024

Basic Mechanisms of Brain Injury and Cognitive Decline in Hypertension.

Caroline E Baggeroer, Francis E Cambronero, N Anna Savan, Angela L Jefferson, Monica M Santisteban

Open access · bronzeAbstract readReview
In one paragraph

Review in Hypertension (Dallas, Tex. : 1979), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
9.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Impaired Intracranial Compliance: A New Hypertension-Mediated Brain Organ Damage?High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2026
    Article
  4. The role of dopamine decline, astrocyte reactivity and cerebral small-vessel disease in cognitive aging.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Article
  5. Article
  6. Article
  7. Ang II-mediated effects on BBB integrity in psychiatric and neurological disorders.Progress in neuro-psychopharmacology & biological psychiatry · 2026
    Review
  8. Article
  9. Current updates on latest basic research of scientific relevance in hypertensive dementia.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Review
  10. Review
  11. Microvascular Health as a Key Determinant of Organismal Aging.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Caroline E BaggeroerVanderbilt Memory and Alzheimer's Center (C.E.B., F.E.C., A.L.J., M.M.S.), Vanderbilt University Medical Center, Nashville, TN.
Francis E CambroneroVanderbilt Memory and Alzheimer's Center (C.E.B., F.E.C., A.L.J., M.M.S.), Vanderbilt University Medical Center, Nashville, TN.
N Anna SavanMedical Scientist Training Program, Yale University, New Haven, CT (N.A.S.).ORCID 0000-0003-3954-7137
Angela L JeffersonVanderbilt Memory and Alzheimer's Center (C.E.B., F.E.C., A.L.J., M.M.S.), Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0002-8245-0587
Monica M SantistebanVanderbilt Memory and Alzheimer's Center (C.E.B., F.E.C., A.L.J., M.M.S.), Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0002-2836-9075
Vanderbilt University Medical Center · USYale University · US

Funding

Vanderbilt Memory & Aging ProjectR01AG034962 · NIA · VANDERBILT UNIVERSITY MEDICAL CENTER · PI JEFFERSON, ANGELA L. · 2011 to 2025
$24.1M
Training in Fundamental NeuroscienceT32MH064913 · NIMH · VANDERBILT UNIVERSITY · PI IHRIE, REBECCA A, WINDER, DANNY G. · 2001 to 2022
$7.6M
Vanderbilt Interdisciplinary Training Program in Alzheimer's DiseaseT32AG058524 · NIA · VANDERBILT UNIVERSITY · PI ANGELA L. JEFFERSON · 2018 to 2026
$3.5M
Risk factors and prevention targets for abnormal cognitive agingK24AG046373 · NIA · VANDERBILT UNIVERSITY MEDICAL CENTER · PI JEFFERSON, ANGELA L. · 2014 to 2023
$1.7M
Neuroimmune Mechanisms of Cognitive Impairment in Salt-sensitive HypertensionK22NS123507 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI SANTISTEBAN FREEMAN, MONICA M · 2021 to 2025
$982k
NIA NIH HHS K24 AG046373NIA NIH HHS R01 AG034962NIA NIH HHS T32 AG058524NIMH NIH HHS T32 MH064913NINDS NIH HHS K22 NS123507
6 · The paper itself

Abstract

Dementia affects almost 50 million adults worldwide, and remains a major cause of death and disability. Hypertension is a leading risk factor for dementia, including Alzheimer disease and Alzheimer disease-related dementias. Although this association is well-established, the mechanisms underlying hypertension-induced cognitive decline remain poorly understood. By exploring the mechanisms mediating the detrimental effects of hypertension on the brain, studies have aimed to provide therapeutic insights and strategies on how to protect the brain from the effects of blood pressure elevation. In this review, we focus on the basic mechanisms contributing to the cerebrovascular adaptions to elevated blood pressure and hypertension-induced microvascular injury. We also assess the cellular mechanisms of neurovascular unit dysfunction, focusing on the premise that cognitive impairment ensues when the dynamic metabolic demands of neurons are not met due to neurovascular uncoupling, and summarize cognitive deficits across various rodent models of hypertension as a resource for investigators. Despite significant advances in antihypertensive therapy, hypertension remains a critical risk factor for cognitive decline, and several questions remain about the development and progression of hypertension-induced cognitive impairment.

Indexed as

Alzheimer DiseaseBrain InjuriesCognitive DysfunctionHypertensionBrainHumanscerebral small vessel diseasecognitive declinedementiahypertensionneurovascular unit

Identifiers

PMID37732479
PMCPMC10840624
OpenAlexW4386910697

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.